Skip to main content
Equibles
PETS logo

PETS · Petmed Express Inc

Track PETS — free

Use PETS with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$1.81 -0.04 (-2.16%) At close · Sep 4
Rebalance outlook locked
Going-concern doubt — cleared Aug 13, 2026

The latest filing states the doubt was alleviated.

“During the three months ended June 30, 2026, management's assessment identified certain conditions and events that, when considered in the aggregate, raised substantial doubt about the Company's ability to continue as a going concern. ... Management determined that these plans are probable of being effectively implemented and are probable of mitigating the conditions that raised substantial doubt. As of the issuance of these financials, management has concluded that substantial doubt about the Company's ability to continue as a going concern for the next twelve months is alleviated by these plans.”
View the 10-Q filed Aug 13, 2026
Market Cap
$39.24M
Shares
21.68M

PETS metrics

63 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$1.81
Market cap
$39.24M

Price action

19 metrics
Price change (1W)
-3.7%
Price change (30D)
-8.1%
Price change (3M)
+7.7%
Price change (6M)
-30.7%
Price change (YTD)
-43.4%
Price change (1Y)
-40.5%
Trailing year
Price change (5Y)
-93.5%
52-week high
$3.90
52-week low
$1.60
Change from 52-week high
-53.6%
Change from 52-week low
+13.1%
Annualized volatility
97.2%
Beta
1.3
RSI (14D)
43.5
Price vs SMA 50
-5.5%
Price vs SMA 200
-23.6%
Avg volume (3M)
633,454
Relative volume
0.1
Average dollar volume
$1.17M

Company

3 metrics
Sector
Healthcare
Industry
Pharmaceutical Retailers
Shares outstanding
21.68M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
0.2×
reciprocal yield 430.3%
P / book
1.7
reciprocal yield 58.6%
FCF yield
—
TTM · current market cap
Buyback yield
0.0%
P / FCF
—
P / operating cash flow
—
Earnings yield
-74.6%

Historical valuation

8 metrics
P / E historical average (3Y)
322.6×
reciprocal yield 0.3%
P / E historical average (5Y)
151.4×
reciprocal yield 0.7%
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
2023-08-11

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-13

Profitability

9 metrics
Gross margin
27.9%
Operating margin
-18.2%
Trailing 12 months
Net margin
-17.3%
Gross profit (TTM)
$47.15M
Operating profit (TTM)
−$30.77M
Net income (TTM)
−$29.28M
Trailing 12 months
Diluted EPS (TTM)
$-1.37
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$3.48

Growth

11 metrics
Revenue growth YoY
-19.9%
Year over year
Net income growth YoY
—
Revenue (TTM)
$168.86M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+4.5%
Year over year · more shares
Revenue CAGR (3Y)
-10.2%
Revenue CAGR (5Y)
-10.0%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-127.4%
Return on assets
-45.9%
Debt / equity
—
Current ratio
0.7
EBITDA (TTM)
−$21.52M
Free cash flow (TTM)
—
Quick ratio
0.5
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$13.08M
Latest balance sheet
Cash & equivalents
$13.08M
Total assets
$63.76M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$23.81M
Capital expenditures (TTM)
$3.96M
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$972,000
R&D / revenue
—
Stock compensation / revenue
0.6%

Ownership (13F)

3 metrics
13F filers
50
13F filer change QoQ
0
Institutional ownership
21.4%

Short interest

3 metrics
Short interest
2.7%
Latest settlement · 5.2 days to cover
Days to cover
5.2d
Short-squeeze score
58 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1040130 CUSIP 716382106 13F (30d) 38 filings 37 filers Visit website Investor relations